Jose Carmona
2021 - Rubius Therapeutics
In 2021, Jose Carmona earned a total compensation of $659.2K as Chief Financial Officer at Rubius Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $200,250 |
---|---|
Salary | $450,000 |
Other | $8,945 |
Total | $659,195 |
Carmona received $450K in salary, accounting for 68% of the total pay in 2021.
Carmona also received $200.3K in non-equity incentive plan and $8.9K in other compensation.
Rankings
In 2021, Jose Carmona's compensation ranked 10,078th out of 12,415 executives tracked by ExecPay. In other words, Carmona earned more than 18.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,078 | 19th |
Manufacturing | 4,462 | 19th |
Chemicals And Allied Products | 1,987 | 16th |
Drugs | 1,765 | 16th |
Biological Products, Except Diagnostic Substances | 383 | 15th |
Carmona's colleagues
We found four more compensation records of executives who worked with Jose Carmona at Rubius Therapeutics in 2021.
News
Rubius Therapeutics CEO Pablo Cagnoni's 2021 pay jumps 45% to $5M
March 30, 2022
Radius Health CEO G Martin's 2020 pay jumps 2,116% to $12M
April 22, 2021
Radius Health CEO Jesper Hoeiland's 2019 pay falls 28% to $3.9M
April 17, 2020
Radius Health CEO Jesper Høiland's 2018 pay falls 29% to $5.4M
April 18, 2019